Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/SANOFI-4698/nieuws/Sanofi-kondigt-tweede-positieve-fase-3-studie-aan-met-Dupixent-Dupilumab-bevestigt-significante-37586509/?utm_source=whatsapp&utm_medium=social&utm_campaign=share